Pronounce: ri-TUX-i-mab hahy-uh-loo-ron-i-deys
Classification: Monoclonal Antibody
Rituximab and hyaluronidase human injection is a synthetic (man-made) antibody directed against a protein called CD20, found on the surface of normal and cancerous B-cells, which are part of the immune system. Once the medication attaches itself to the B cells expressing CD20, it causes these cells to die. This process kills cancer cells, but can also kill functioning B cells, temporarily affecting the ability of the immune system to fight infections. Hyaluronidase is an enzyme that is used in this medication to increase the absorption of rituximab when it is given subcutaneously (into the skin).
Rituximab and hyaluronidase human injection is given by subcutaneous injection (a needle inserted under the skin in the stomach (abdomen) area). Do not inject into areas where the skin is red, bruised, tender or hard, or where there are moles or scars. The injection may be given over several minutes. The dosage and schedule is determined by the type of cancer and treatment regimen.
Prior to each dose, you will be given acetaminophen, diphenhydramine, and possibly a corticosteroid, to help prevent any reactions. This form of rituximab is only used after having received at least one dose by intravenous (IV) infusion, without any reactions.
There are a number of things you can do to manage the side effects of rituximab and hyaluronidase human injection. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
Severe skin and mouth reactions can occur on this medication. Notify your healthcare provider right away if you develop any rash, peeling skin, or painful sores or blisters on your skin, lips, inside of your mouth, or genitals.
This medication can cause Hepatitis B reactivation in patients who have previously had hepatitis. This can occur up to 24 months after receiving this medication. Be sure your healthcare provider is aware of any previous Hepatitis B diagnosis and treatment. You will also be tested for the Hepatitis B virus prior to beginning treatment with this medication. Notify your healthcare provider if you develop yellowing of your skin or the whites of your eyes.
PML is a rare but very serious brain infection that has been reported with this medication. The signs of PML may develop over several weeks or months. They may include changes in mood or usual behavior, confusion, thinking problems, loss of memory, changes in vision, speech, or walking, and decreased strength or weakness on one side of the body. If you develop any of these signs, notify your healthcare provider immediately.
This medication can increase your risk of developing an infection and lower the ability of your immune system to fight infections, with or without a decrease in white blood cell counts. This risk can last for up to a year after stopping this medication.
White blood cells (WBC) are important for fighting infection. While receiving treatment, your WBC count can drop, putting you at a higher risk of getting an infection. You should let your doctor or nurse know right away if you have a fever (temperature greater than 100.4°F or 38°C), sore throat or cold, shortness of breath, cough, burning with urination, or a sore that doesn't heal.
Tips to preventing infection:
Allergic or infusion reactions may occur during the treatment or up to 24 hours after the dose. This is less common after the first treatment. You will be given an antihistamine, such as diphenhydramine, acetaminophen (Tylenol®), and possibly a corticosteroid, before your treatment to reduce the chances of having a reaction.
Notify your healthcare provider or get medical help right away if you experience any of the following during or after an injection of this medication: difficulty breathing or swallowing, chest pain, feel like your heart is racing, sudden cough or wheezing, swelling of lips, tongue, throat or face, develop itching, rash or hives, lightheadedness, fever, chills, or shakes. Additional medications may be given to alleviate your discomfort. You may experience pain, swelling, hardness, redness, bleeding, itching, or rash at the injection site.
Talk to your doctor or nurse so they can prescribe medications to help you manage nausea and vomiting. In addition, dietary changes may help. Avoid things that may worsen the symptoms, such as heavy or greasy/fatty, spicy, or acidic foods (lemons, tomatoes, oranges). Try antacids, (e.g. milk of magnesia, calcium tablets such as Tums), saltines, or ginger ale to lessen symptoms.
Call your doctor or nurse if you are unable to keep fluids down for more than 12 hours or if you feel lightheaded or dizzy at any time.
This medication affects how well your immune system works and makes it harder for your body to fight infections. You should not receive rituximab and hyaluronidase human injection if you have an active infection. You, or anyone you live with, should avoid having live or live-attenuated vaccines while receiving this medication. These include oral polio, measles, nasal flu vaccine (FluMist®), rotavirus, and yellow fever vaccines.
If you have chronic lymphocytic leukemia (CLL), you will also receive medications to prevent certain infections during treatment, and for up to 12 months after treatment is finished.
Your red blood cells are responsible for carrying oxygen to the tissues in your body. When the red cell count is low, you may feel tired or weak. You should let your doctor or nurse know if you experience any shortness of breath, difficulty breathing, or pain in your chest. If the count gets too low, you may receive a blood transfusion.
Platelets help your blood clot, so when the count is low you are at a higher risk of bleeding. Let your doctor or nurse know if you have any excess bruising or bleeding, including nose bleeds, bleeding gums or blood in your urine or stool. If the platelet count becomes too low, you may receive a transfusion of platelets.
Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help. Talk to your healthcare team for helpful tips on dealing with this side effect.
There are several things you can do to prevent or relieve constipation. Include fiber in your diet (fruits and vegetables), drink 8-10 glasses of non-alcoholic fluids a day, and keep active. A stool softener once or twice a day may prevent constipation. If you do not have a bowel movement for 2-3 days, you should contact your healthcare team for suggestions to relieve the constipation.
Your hair may become thin, brittle, or may fall out. This typically begins two to three weeks after treatment starts. This hair loss can be all body hair, including pubic, underarm, legs/arms, eyelashes, and nose hairs. The use of scarves, wigs, hats, and hairpieces may help. Hair generally starts to regrow soon after treatment is completed. Remember your hair helps keep you warm in cold weather, so a hat is particularly important in cold weather or to protect you from the sun.
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is necessary during treatment and for at least 12 months after treatment. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should not breastfeed while receiving this medication, or for 6 months after your last dose.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania